Managing Director, Sydney
Stephen is a founding partner of Brandon Capital Partners.
Previously Stephen worked with Bio Innovation SA and helped establish Terra Rossa Capital. Prior to this Stephen was a Director of Apax Partners, a leading international private equity group based in London. Before joining Apax Partners, he fulfilled roles in product development with UK biotechnology company Cantab Pharmaceuticals. Earlier, Stephen spent ten years as a research immunologist in London and California.
Stephen is a Director of Auspherix Ltd, Elastagen P/L, Heart Metabolics Ltd, OncoRes Medical P/L, Vaxxas P/L and a Council Member of the Australian Venture Capital Association Limited (AVCAL). Stephen has an Honours degree in Immunology and Biochemistry, a PhD in Immunology from Kings College London and an MBA, specialising in Entrepreneurship, from Imperial College London. Stephen is a Graduate of the Australian Institute of Company Directors and a member of AusBiotech.